This inventor holds 2 USPTO granted patents. Top assignee: Pharmacia Ab. Active years: 2005-2006.
Company Filing History:
Years Active: 2005-2006
Title: Malin Ottosson: Innovator in Metabolic Syndrome Treatment
Introduction
Malin Ottosson is a notable inventor based in Gothenburg, Sweden. She has made significant contributions to the field of medicine, particularly in the treatment of metabolic syndrome. With a total of 2 patents to her name, her work focuses on innovative methods to address health issues related to insulin resistance and associated conditions.
Latest Patents
Malin Ottosson's latest patents include groundbreaking methods for treating patients with metabolic syndrome. One of her patents describes a method for treating a patient exhibiting primary insulin resistance and hypertension. This method involves administering human growth hormone or a functional analog in an effective amount to decrease lipoprotein aberrations or hypertension. Another patent outlines a method aimed at decreasing insulin resistance in patients with metabolic syndrome and abdominal obesity. This method also utilizes growth hormone or its functional derivatives to achieve effective results.
Career Highlights
Malin Ottosson has established herself as a key figure in her field through her innovative research and development efforts. Her work at Pharmacia AB has allowed her to explore and implement new treatment methodologies that have the potential to improve patient outcomes significantly.
Collaborations
Malin has collaborated with esteemed colleagues, including Lars Lönn and Lars Sjöström, to advance her research and develop effective treatment strategies. These collaborations have played a crucial role in enhancing the impact of her work.
Conclusion
Malin Ottosson's contributions to the treatment of metabolic syndrome highlight her dedication to medical innovation. Her patents reflect her commitment to improving health outcomes for patients facing insulin resistance and related conditions.